6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Originaltext

Diese Übersetzung bewerten

Mit deinem Feedback können wir Google Übersetzer weiter verbessern

Latest Press Releases

Time	Headline
Just now	Supermicro Expands Data Center Building Block Solutions® Flexibility with Arm-Based Platforms and OCP Systems for Next-Gen AI Infrastructure
Just now	Appian Advances AI in Process to Deliver Enterprise Outcomes at Scale
1m ago	Usio Launches New Private-Label Gift Card Platform
1m ago	MiniMed announces Health Canada License for Simplera Sync™ Sensor, Type 2 Diabetes Indication with MiniMed™ 780G System
2m ago	T-Mobile Strengthens Next-Generation Broadband Portfolio with Two Strategic Fiber Partnerships

About

Denali Therapeutics Inc (NASDAQ:DNLI) — investor relations, events, news, and company updates on 6ix.

Latest News

Orsini Selected as the Exclusive Specialty Pharmacy and Home Infusion Partner for Denali Therapeutics' AVLAYAH™ (tividenofusp alfa-eknm)

Denali Therapeutics Regains Full Rights to Investigational Therapy DNL593 (PTV:PGRN) for GRN-related Frontotemporal Dementia (FTD-GRN)

Denali Therapeutics Announces U.S. FDA Approval of AVLAYAH™ (tividenofusp alfa-eknm) for Treatment of Hunter Syndrome (MPS II)

Denali Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Business Highlights

Denali Therapeutics Presents Enzyme TransportVehicle™ Progress Across Three Clinical Programs for Treatment of Lysosomal Storage Disorders at 2026 WORLDSymposium™

Financials

Revenue

$0

Market Cap

$3.27 B

EPS

-2.97

Community Chat

Ask AI